W

Walvax Biotechnology Co Ltd
SZSE:300142

Watchlist Manager
Walvax Biotechnology Co Ltd
SZSE:300142
Watchlist
Price: 14.46 CNY -5.61% Market Closed
Market Cap: 23.1B CNY
Have any thoughts about
Walvax Biotechnology Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Walvax Biotechnology Co Ltd stock under the Base Case scenario is 15.56 CNY. Compared to the current market price of 14.46 CNY, Walvax Biotechnology Co Ltd is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
15.56 CNY
Undervaluation 7%
Intrinsic Value
Price
W
Worst Case
Base Case
Best Case

Valuation Backtest
Walvax Biotechnology Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Walvax Biotechnology Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Walvax Biotechnology Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Walvax Biotechnology Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Walvax Biotechnology Co Ltd

Provide an overview of the primary business activities
of Walvax Biotechnology Co Ltd.

What unique competitive advantages
does Walvax Biotechnology Co Ltd hold over its rivals?

What risks and challenges
does Walvax Biotechnology Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Walvax Biotechnology Co Ltd.

Provide P/S
for Walvax Biotechnology Co Ltd.

Provide P/E
for Walvax Biotechnology Co Ltd.

Provide P/OCF
for Walvax Biotechnology Co Ltd.

Provide P/FCFE
for Walvax Biotechnology Co Ltd.

Provide P/B
for Walvax Biotechnology Co Ltd.

Provide EV/S
for Walvax Biotechnology Co Ltd.

Provide EV/GP
for Walvax Biotechnology Co Ltd.

Provide EV/EBITDA
for Walvax Biotechnology Co Ltd.

Provide EV/EBIT
for Walvax Biotechnology Co Ltd.

Provide EV/OCF
for Walvax Biotechnology Co Ltd.

Provide EV/FCFF
for Walvax Biotechnology Co Ltd.

Provide EV/IC
for Walvax Biotechnology Co Ltd.

Show me price targets
for Walvax Biotechnology Co Ltd made by professional analysts.

What are the Revenue projections
for Walvax Biotechnology Co Ltd?

How accurate were the past Revenue estimates
for Walvax Biotechnology Co Ltd?

What are the Net Income projections
for Walvax Biotechnology Co Ltd?

How accurate were the past Net Income estimates
for Walvax Biotechnology Co Ltd?

What are the EPS projections
for Walvax Biotechnology Co Ltd?

How accurate were the past EPS estimates
for Walvax Biotechnology Co Ltd?

What are the EBIT projections
for Walvax Biotechnology Co Ltd?

How accurate were the past EBIT estimates
for Walvax Biotechnology Co Ltd?

Compare the revenue forecasts
for Walvax Biotechnology Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Walvax Biotechnology Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Walvax Biotechnology Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Walvax Biotechnology Co Ltd compared to its peers.

Compare the P/E ratios
of Walvax Biotechnology Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Walvax Biotechnology Co Ltd with its peers.

Analyze the financial leverage
of Walvax Biotechnology Co Ltd compared to its main competitors.

Show all profitability ratios
for Walvax Biotechnology Co Ltd.

Provide ROE
for Walvax Biotechnology Co Ltd.

Provide ROA
for Walvax Biotechnology Co Ltd.

Provide ROIC
for Walvax Biotechnology Co Ltd.

Provide ROCE
for Walvax Biotechnology Co Ltd.

Provide Gross Margin
for Walvax Biotechnology Co Ltd.

Provide Operating Margin
for Walvax Biotechnology Co Ltd.

Provide Net Margin
for Walvax Biotechnology Co Ltd.

Provide FCF Margin
for Walvax Biotechnology Co Ltd.

Show all solvency ratios
for Walvax Biotechnology Co Ltd.

Provide D/E Ratio
for Walvax Biotechnology Co Ltd.

Provide D/A Ratio
for Walvax Biotechnology Co Ltd.

Provide Interest Coverage Ratio
for Walvax Biotechnology Co Ltd.

Provide Altman Z-Score Ratio
for Walvax Biotechnology Co Ltd.

Provide Quick Ratio
for Walvax Biotechnology Co Ltd.

Provide Current Ratio
for Walvax Biotechnology Co Ltd.

Provide Cash Ratio
for Walvax Biotechnology Co Ltd.

What is the historical Revenue growth
over the last 5 years for Walvax Biotechnology Co Ltd?

What is the historical Net Income growth
over the last 5 years for Walvax Biotechnology Co Ltd?

What is the current Free Cash Flow
of Walvax Biotechnology Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Walvax Biotechnology Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Walvax Biotechnology Co Ltd

Current Assets 7.5B
Cash & Short-Term Investments 3.3B
Receivables 3.1B
Other Current Assets 1B
Non-Current Assets 7.6B
Long-Term Investments 1.7B
PP&E 4.1B
Intangibles 1.5B
Other Non-Current Assets 245.8m
Current Liabilities 2.5B
Accounts Payable 1.6B
Accrued Liabilities 574.4m
Short-Term Debt 248.4m
Other Current Liabilities 158.6m
Non-Current Liabilities 3B
Long-Term Debt 479.5m
Other Non-Current Liabilities 2.6B
Efficiency

Earnings Waterfall
Walvax Biotechnology Co Ltd

Revenue
3.4B CNY
Cost of Revenue
-633.4m CNY
Gross Profit
2.7B CNY
Operating Expenses
-2.3B CNY
Operating Income
422.6m CNY
Other Expenses
-287.9m CNY
Net Income
134.7m CNY

Free Cash Flow Analysis
Walvax Biotechnology Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Walvax Biotechnology Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive Net Income
Positive 3-Year Average ROIC
49/100
Profitability
Score

Walvax Biotechnology Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Walvax Biotechnology Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
72/100
Solvency
Score

Walvax Biotechnology Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Walvax Biotechnology Co Ltd

Wall Street analysts forecast Walvax Biotechnology Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Walvax Biotechnology Co Ltd is 12.24 CNY with a low forecast of 12.12 CNY and a high forecast of 12.6 CNY.

Lowest
Price Target
12.12 CNY
16% Downside
Average
Price Target
12.24 CNY
15% Downside
Highest
Price Target
12.6 CNY
13% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Walvax Biotechnology Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Walvax Biotechnology Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Walvax Biotechnology Co Ltd

Country

China

Industry

Biotechnology

Market Cap

23.2B CNY

Dividend Yield

0.07%

Description

Walvax Biotechnology Co., Ltd. engages in the research and development, production, and sale of biopharmaceutical products. The company is headquartered in Kunming, Yunnan and currently employs 1,866 full-time employees. The company went IPO on 2010-11-12. The Company’s main products include haemophilus influenza type b conjugate vaccines, freeze-dried group A,C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines and group A and C meningococcal polysaccharide vaccines, among others. The firm distributes its products mainly in domestic market.

Contact

YUNNAN
Kunming
19F, Tower A, Building 9, Dingyi Tiancheng, No.99, Keyuan Road, High-Tech Zone
+8687168312779
www.walvax.com

IPO

2010-11-12

Employees

1 866

Officers

Director & President
Mr. Runsheng Jiang
Chief Financial Officer
Ms. Hua Zhou
Director of Operations
Ms. Yun Yan Wu
Chief Investment Officer
Mr. Jin Long Zhao
Technical Director
Ms. Lin Yuan
Marketing Director
Mr. Wei Yao
Show More
Director of Human Resources
Mr. Qing Gongsun
VP & Director
Mr. Shao Zhong Dong
Board Secretary
Mr. Yu Ran Liu
Show Less

See Also

Discover More
What is the Intrinsic Value of one Walvax Biotechnology Co Ltd stock?

The intrinsic value of one Walvax Biotechnology Co Ltd stock under the Base Case scenario is 15.56 CNY.

Is Walvax Biotechnology Co Ltd stock undervalued or overvalued?

Compared to the current market price of 14.46 CNY, Walvax Biotechnology Co Ltd is Undervalued by 7%.

Back to Top